Cardiology Guidelines + Journal Rundown (May 2024)

Cardiology Guidelines + Journal Rundown Cardiology

In this post, we will be taking a closer look at some of the most popular cardiology-related articles that have been published during the months of April and May 2024.

Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures

JAMA Cardiology
April 2024
The association between antibiotic prophylaxis and infective endocarditis after invasive dental procedures is still unclear. Indications for antibiotic prophylaxis were restricted by guidelines beginning in 2007. To systematically review and analyze existing evidence on the association between antibiotic prophylaxis and infective endocarditis following invasive dental procedures.
Abstract Link
Full Text Link

Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association

Circulation
April 2024
The lack of randomized clinical trials in cardiac sarcoidosis has led to treatment decisions based on cohort studies and consensus opinions, with substantial variation observed across centers. This scientific statement is intended to guide clinical practice and to facilitate management conformity by providing a framework for the diagnosis and management of cardiac sarcoidosis.
Abstract Link
Full Text Link

Stress and Cardiovascular Disease: an Update

Nature Reviews Cardiology
May 2024
Psychological stress has long been associated with negative health consequences, particularly cardiovascular disease, but the mechanisms and potential causal links have remained speculative. Physiological responses to stress are emerging as key pathways for the risk of cardiovascular disease, especially haemodynamic, vascular and immune perturbations triggered by stress. More data are needed from prospective studies and from assessments in real-life situations.
Full Text Link

Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity

Journal of the American College of Cardiology (JACC)
April 2024
The mechanisms underlying the psychological and cardiovascular disease (CVD) benefits of physical activity (PA) are not fully understood.
Abstract Link
Full Text Link

Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure

Hypertension
April 2024
Quantification of total cardiovascular risk is essential for individualizing hypertension treatment. This study aimed to develop and validate a novel, machine-learning-derived model to predict cardiovascular mortality risk using office blood pressure (OBP) and ambulatory blood pressure (ABP).
Abstract Link
Full Text Link

Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity

Journal of the American College of Cardiology (JACC)
April 2024
The mechanisms underlying the psychological and cardiovascular disease (CVD) benefits of physical activity (PA) are not fully understood.
Abstract Link
Full Text Link

Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control

Hypertension (AHA Journals)
April 2024
In this review, we address this deficiency by examining and advocating for the incorporation of dietary fiber as a key lifestyle modification to manage elevated BP. We explain what dietary fiber is, review the existing literature that supports its use to lower BP and prevent cardiovascular disease, describe the mechanisms involved, propose evidence-based target levels of fiber intake, provide examples of how patients can achieve the recommended targets, and discuss outstanding questions in the field.
Abstract Link
Full Text Link

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

The New England Journal of Medicine (NEJM)
April 2024
Most trials that have shown a benefit of beta-blocker treatment after myocardial infarction included patients with large myocardial infarctions and were conducted in an era before modern biomarker-based diagnosis of myocardial infarction and treatment with percutaneous coronary intervention, antithrombotic agents, high-intensity statins, and renin-angiotensin-aldosterone system antagonists.
Abstract Link
Full Text Link

Artificial Intelligence–Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood Pressure

Hypertension
April 2024
Quantification of total cardiovascular risk is essential for individualizing hypertension treatment. This study aimed to develop and validate a novel, machine-learning-derived model to predict cardiovascular mortality risk using office blood pressure (OBP) and ambulatory blood pressure (ABP).
Abstract Link
Full Text Link

Long-Term Effect of Salt Substitution for Cardiovascular Outcomes: A Systematic Review and Meta-Analysis

Annals of Internal Medicine
April 2024
Salt substitution is a simple yet increasingly promising strategy to improve cardiovascular outcomes.
Abstract Link
Full Text Link

Effect of Stress-Related Neural Pathways on the Cardiovascular Benefit of Physical Activity

Journal of the American College of Cardiology (JACC)
April 2024
The mechanisms underlying the psychological and cardiovascular disease (CVD) benefits of physical activity (PA) are not fully understood.
Abstract Link
Full Text Link

Recommendations for the Use of Dietary Fiber to Improve Blood Pressure Control

Hypertension (AHA Journals)
April 2024
In this review, we address this deficiency by examining and advocating for the incorporation of dietary fiber as a key lifestyle modification to manage elevated BP. We explain what dietary fiber is, review the existing literature that supports its use to lower BP and prevent cardiovascular disease, describe the mechanisms involved, propose evidence-based target levels of fiber intake, provide examples of how patients can achieve the recommended targets, and discuss outstanding questions in the field.

Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine — Oregon, June 2021–December 2022

Morbidity and Mortality Weekly Report (MMWR)
April 2024
To determine risk for sudden cardiac death among adolescents and young adults after COVID-19 vaccination, investigators examined June 2021–December 2022 Oregon death certificate data for decedents aged 16–30 years. Of 40 deaths that occurred among persons who had received an mRNA COVID-19 vaccine dose, three occurred ≤100 days after vaccination. Among these, two occurred in persons with underlying.
Full Text Link

There you have it – a look at some of the most popular cardiology publications released in April and May 2024. Sign up for alerts and stay informed on the latest published guidelines and articles.